苏州丰倍生物科技股份有限公司首次公开发行股票并在主板上市网上路演公告

Core Points - Suzhou Fengbei Biotechnology Co., Ltd. has received approval for its initial public offering (IPO) of RMB ordinary shares (A-shares) and will be listed on the main board [1] - The IPO will be managed by Guotai Junan Securities Co., Ltd. as the sponsor and lead underwriter [1] - The offering will include a combination of strategic placement, offline issuance to qualified investors, and online issuance to the public [1] Summary by Sections - IPO Details - The total number of new shares to be issued is 35.9 million, representing 25.02% of the total share capital post-issuance [2] - Initial strategic placement will consist of 7.18 million shares, accounting for 20.00% of the total issuance [2] - The offline initial issuance will be 17.23 million shares, making up 60.00% of the remaining shares after strategic placement [2] - The online initial issuance will be 11.49 million shares, representing 40.00% of the remaining shares after strategic placement [2] - Roadshow Information - The online roadshow is scheduled for October 24, 2025, from 14:00 to 17:00 [3] - The roadshow will be accessible via the Shanghai Stock Exchange Roadshow Center and other platforms [3] - Key participants will include members of the company's board and management, along with representatives from the lead underwriter [3]